MSP Recovery (LIFW) Competitors

$0.76
-0.02 (-3.15%)
(As of 02:01 PM ET)

LIFW vs. SY, NHIQ, ADEX, ABEO, VTGN, TBRG, KPTI, TELA, OMGA, and NOTV

Should you be buying MSP Recovery stock or one of its competitors? The main competitors of MSP Recovery include So-Young International (SY), NantHealth (NHIQ), Adit EdTech Acquisition (ADEX), Abeona Therapeutics (ABEO), Vistagen Therapeutics (VTGN), TruBridge (TBRG), Karyopharm Therapeutics (KPTI), TELA Bio (TELA), Omega Therapeutics (OMGA), and Inotiv (NOTV). These companies are all part of the "medical" sector.

MSP Recovery vs.

MSP Recovery (NASDAQ:LIFW) and So-Young International (NASDAQ:SY) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their community ranking, risk, media sentiment, valuation, dividends, institutional ownership, analyst recommendations, earnings and profitability.

3.8% of MSP Recovery shares are held by institutional investors. Comparatively, 35.3% of So-Young International shares are held by institutional investors. 19.4% of MSP Recovery shares are held by company insiders. Comparatively, 16.7% of So-Young International shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

So-Young International has a net margin of 1.37% compared to MSP Recovery's net margin of -724.07%. So-Young International's return on equity of 0.81% beat MSP Recovery's return on equity.

Company Net Margins Return on Equity Return on Assets
MSP Recovery-724.07% -3.49% -1.72%
So-Young International 1.37%0.81%0.65%

So-Young International has higher revenue and earnings than MSP Recovery. MSP Recovery is trading at a lower price-to-earnings ratio than So-Young International, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MSP Recovery$7.70M13.91-$56.35M-$6.26-0.12
So-Young International$210.99M0.57$3M$0.0340.68

MSP Recovery has a beta of -2.21, suggesting that its stock price is 321% less volatile than the S&P 500. Comparatively, So-Young International has a beta of 0.9, suggesting that its stock price is 10% less volatile than the S&P 500.

In the previous week, MSP Recovery had 2 more articles in the media than So-Young International. MarketBeat recorded 4 mentions for MSP Recovery and 2 mentions for So-Young International. So-Young International's average media sentiment score of 1.20 beat MSP Recovery's score of 0.27 indicating that So-Young International is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
MSP Recovery
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
So-Young International
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
MSP Recovery
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
So-Young International
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

So-Young International received 55 more outperform votes than MSP Recovery when rated by MarketBeat users.

CompanyUnderperformOutperform
MSP RecoveryN/AN/A
So-Young InternationalOutperform Votes
55
64.71%
Underperform Votes
30
35.29%

Summary

So-Young International beats MSP Recovery on 11 of the 14 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LIFW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LIFW vs. The Competition

MetricMSP RecoveryData processing & preparation IndustryMedical SectorNASDAQ Exchange
Market Cap$107.08M$3.54B$5.09B$7.95B
Dividend YieldN/A2.05%36.91%3.91%
P/E Ratio-0.1216.94136.5415.87
Price / Sales13.916.282,355.1677.37
Price / Cash0.2748.6935.9432.08
Price / Book0.077.175.734.68
Net Income-$56.35M$19.79M$105.05M$216.91M
7 Day Performance-11.19%0.83%2.20%3.05%
1 Month Performance-18.88%11.95%4.51%6.33%
1 Year Performance-93.74%2.88%6.82%10.03%

MSP Recovery Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SY
So-Young International
0 of 5 stars
$1.38
+6.2%
N/A-55.2%$136.95M$210.99M46.021,357
NHIQ
NantHealth
0 of 5 stars
$1.50
flat
N/AN/A$48.90M$67M0.00365Gap Up
ADEX
Adit EdTech Acquisition
0 of 5 stars
$5.38
flat
N/AN/A$47.88M$19.62M0.007High Trading Volume
ABEO
Abeona Therapeutics
4.215 of 5 stars
$4.40
-3.5%
$36.00
+718.2%
+51.8%$120.34M$3.50M-1.71N/AAnalyst Forecast
VTGN
Vistagen Therapeutics
2.1479 of 5 stars
$4.45
-4.5%
$19.00
+327.0%
+8.3%$120.24M$1.11M0.0037
TBRG
TruBridge
3.7438 of 5 stars
$8.27
+1.5%
$18.50
+123.7%
N/A$121.18M$339.44M-2.633,219Insider Buying
KPTI
Karyopharm Therapeutics
4.0587 of 5 stars
$1.02
-7.3%
$4.80
+370.6%
-52.3%$118.80M$146.03M-0.82325Gap Up
TELA
TELA Bio
1.8881 of 5 stars
$4.80
-2.4%
$13.67
+184.7%
-32.8%$118.32M$58.45M-2.32227
OMGA
Omega Therapeutics
1.974 of 5 stars
$2.15
-0.5%
$10.00
+366.2%
-71.5%$118.30M$3.09M-1.1993Analyst Revision
Gap Up
NOTV
Inotiv
3.0706 of 5 stars
$4.75
+0.8%
$15.17
+219.3%
-65.9%$122.50M$572.42M-3.652,055Analyst Downgrade
News Coverage
Gap Down

Related Companies and Tools

This page (NASDAQ:LIFW) was last updated on 5/17/2024 by MarketBeat.com Staff

From Our Partners